Show simple item record

dc.contributor.authorHayward, C
dc.date.accessioned2020-12-10T08:42:13Z
dc.date.available2020-12-10T08:42:13Z
dc.date.issued2020
dc.identifier.citation

Stevens, K. et al. (2020). Statistical Analysis Plan for the PD-STAT trial (Simvastatin as a neuroprotective treatment for Parkinson’s disease: a double-blind, randomised, placebo controlled futility study in patients of moderate severity). PEARL Research Repository https://doi.org/10.24382/dkb9-ns80

dc.identifier.urihttp://hdl.handle.net/10026.1/16728
dc.descriptionThe study protocol includes an outline of the statistical methods to be employed in the analysis of the trial data. The purpose of the Statistical Analysis Plan (SAP) is to provide full details of the planned statistical methods to be used in the primary report of the trial results. The SAP has been drafted following published SAP Guidelines6, also taking cognisance of the CONSORT for parallel group trials7, the extension for reporting patient-reported outcomes8 and Harms9. However, it is worth noting that, as this is a futility trial, there will be some differences in the analysis of the outcome measures and presentation of the results compared to a typical definitive randomised trial. The electromagnetic sensor measurement and genetic sub-studies will be analysed separately by collaborators on the PD-STAT project. The statistical analyses outlined in this SAP do not pertain to data gathered from either of these sub-studies.
dc.description.abstract

The main objective of this trial was to determine the futility of Simvastatin in reducing neurodegenerative decline in patients with PD. The outcome measures will be recorded at baseline, 12, 24 and 26 months.

dc.language.isoen
dc.titleSimvastatin as a neuroprotective treatment for Parkinson’s disease: a double-blind, randomised, placebo controlled futility study in patients of moderate severity
dc.typedataset
dc.typeDataset
dc.identifier.doihttps://doi.org/10.24382/dkb9-ns80
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Users by role
dc.rights.embargoperiodNot known
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeOther


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV